Antiplatelet therapy increases symptomatic ICH risk after thrombolysis and thrombectomy

Marie Couture, Gaultier Marnat, Romain Griffier, Florent Gariel, Stéphane Olindo, Pauline Renou, Sharmila Sagnier, Jerome Berge, Thomas Tourdias, Igor Sibon

Open source

DOI
10.1111/ane.13468
Published
2021-05-27
Container
Acta Neurologica Scandinavica
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/ane.13468,
  title = {Antiplatelet therapy increases symptomatic ICH risk after thrombolysis and thrombectomy},
  author = {Marie Couture and Gaultier Marnat and Romain Griffier and Florent Gariel and Stéphane Olindo and Pauline Renou and Sharmila Sagnier and Jerome Berge and Thomas Tourdias and Igor Sibon},
  year = {2021},
  journal = {Acta Neurologica Scandinavica},
  doi = {10.1111/ane.13468},
  url = {https://doi.org/10.1111/ane.13468}
}

RIS

TY  - JOUR
TI  - Antiplatelet therapy increases symptomatic ICH risk after thrombolysis and thrombectomy
AU  - Marie Couture
AU  - Gaultier Marnat
AU  - Romain Griffier
AU  - Florent Gariel
AU  - Stéphane Olindo
AU  - Pauline Renou
AU  - Sharmila Sagnier
AU  - Jerome Berge
AU  - Thomas Tourdias
AU  - Igor Sibon
PY  - 2021
JO  - Acta Neurologica Scandinavica
DO  - 10.1111/ane.13468
UR  - https://doi.org/10.1111/ane.13468
ER  - 

APA

Couture, M., Marnat, G., Griffier, R., Gariel, F., Olindo, S., Renou, P., Sagnier, S., Berge, J., Tourdias, T., & Sibon, I. (2021). Antiplatelet therapy increases symptomatic ICH risk after thrombolysis and thrombectomy. Acta Neurologica Scandinavica. https://doi.org/10.1111/ane.13468

Source records